Clinical use of crizotinib for the treatment of non-small cell lung cancer
Patrick J Roberts Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA Absract: Discoveries over the last decade have fundamentally transformed the way we define lung cancer. Gone are the days of the simple binary classification system of non-smal...
Main Author: | Roberts PJ |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-04-01
|
Series: | Biologics : Targets & Therapy |
Online Access: | http://www.dovepress.com/clinical-use-of-crizotinib-for-the-treatment-of-non-small-cell-lung-ca-a12876 |
Similar Items
-
Clinical Research of Crizotinib in Advanced Non-small Cell Lung Cancer
by: Haibo ZHU, et al.
Published: (2013-06-01) -
Sequential treatment with alectinib in crizotinib-resistant non-small-cell lung cancer
by: Swaratika Majumdar, et al.
Published: (2018-01-01) -
Clinical Efficacy of Crizotinib in Advanced ALK Positive
Non-small Cell Lung Cancer
by: Jing ZHAO, et al.
Published: (2015-10-01) -
Interstitial Lung Disease Induced by Crizotinib in Non-Small-Cell Lung Cancer
by: Andreia Tereso, et al.
Published: (2019-03-01) -
Role of Crizotinib in previously treated non-small-cell lung cancer
by: Sunil Kumar Gupta
Published: (2014-01-01)